Clinical Trial Update: COMPASSION XT PAS - Post-approval Study of the SAPIEN XT THV in Patients With Pulmonary Valve Dysfunction

View source ↗

Summary

Post-approval study evaluating Edwards Lifesciences' SAPIEN XT transcatheter heart valve for pulmonary valve dysfunction in patients with congenital heart disea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease
• Pulmonary Valve Insufficiency
• Pulmonary Valve Stenosis

Drugs mentioned

• SAPIEN XT Transcatheter Heart Valve

Snippet

Sponsor: Edwards Lifesciences | Conditions: Pulmonary Valve Insufficiency, Pulmonary Valve Stenosis | Status: COMPLETED